The use of circulating cell-free tumor DNA in routine diagnostics of metastatic melanoma patients

Modern advances in technology such as next-generation sequencing and digital PCR make detection of minor circulating cell-free tumor DNA amounts in blood from cancer patients possible. Samples can be obtained minimal-invasively, tested for treatment-determining genetic alterations and are considered...

Descripción completa

Detalles Bibliográficos
Autores principales: Knuever, Jana, Weiss, Jonathan, Persa, Oana-Diana, Kreuzer, Karl, Mauch, Cornelia, Hallek, Michael, Schlaak, Max
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080785/
https://www.ncbi.nlm.nih.gov/pubmed/32188904
http://dx.doi.org/10.1038/s41598-020-61818-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080785/
https://www.ncbi.nlm.nih.gov/pubmed/32188904
http://dx.doi.org/10.1038/s41598-020-61818-1

Ejemplares similares